Recombinant Zoster Vaccine Reduces All‐Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune‐Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large‐Scale Real‐World Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Medical Virology"
DOI: 10.1002/jmv.70285
Abstract: This study aims to assess the impact of recombinant zoster vaccine (RZV) on the risk of major cardiovascular events (MACE) in patients with rheumatoid arthritis (RA), spondyloarthritis (SpA), or psoriatic diseases who are receiving Janus… read more here.
Keywords: cause mortality; mortality; diseases receiving; recombinant zoster ... See more keywords
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials
Sign Up to like & getrecommendations! Published in 2021 at "Drug Safety"
DOI: 10.1007/s40264-021-01076-w
Abstract: The adjuvanted recombinant zoster vaccine (RZV) has demonstrated high efficacy against herpes zoster in older adults and immunocompromised populations. We present comprehensive safety data from six clinical trials in immunocompromised populations (autologous hematopoietic stem cell… read more here.
Keywords: zoster vaccine; safety; herpes zoster; recombinant zoster ... See more keywords
Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
Sign Up to like & getrecommendations! Published in 2021 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2021.04.017
Abstract: PURPOSE To examine the effectiveness of the recombinant zoster vaccine for preventing herpes zoster ophthalmicus in the general US population. DESIGN Retrospective, observational cohort study. PARTICIPANTS Individuals enrolled in the OptumLabs® Data Warehouse (OLDW) (OptumLabs,… read more here.
Keywords: zoster vaccine; recombinant zoster; herpes zoster; zoster ophthalmicus ... See more keywords
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac011
Abstract: Abstract Background The 2-dose recombinant zoster vaccine (RZV) series is recommended for prevention of herpes zoster (HZ) in adults aged ≥50 years, but data are limited on the impact of concomitant administration with other vaccines on… read more here.
Keywords: rzv; vaccination; without concomitant; recombinant zoster ... See more keywords
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares.
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the rheumatic diseases"
DOI: 10.1136/annrheumdis-2019-216639
Abstract: We have read with great interest the article addressing the risk of gout flares after vaccination in a case crossover study by Yokose et al .1 The authors suggest that vaccines may be associated with… read more here.
Keywords: zoster vaccine; gout flares; recombinant zoster; gout ... See more keywords
Disparities in Recombinant Zoster Vaccine Coverage in the United States.
Sign Up to like & getrecommendations! Published in 2025 at "Population health management"
DOI: 10.1177/19427891251392576
Abstract: Recombinant zoster vaccine (RZV) was recommended in 2020 in the US for adults aged ≥50 years. This retrospective study used cross-sectional data from 2020 National Health Interview Survey respondents aged ≥50 years. Sample weights were… read more here.
Keywords: coverage; zoster vaccine; recombinant zoster; aged years ... See more keywords
Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10081339
Abstract: Increasing numbers of patients with zoster were reported recently, and recombinant zoster vaccine (Shingrix®) was licensed using the AS01B adjuvant system. Although it induces highly effective protection, a high incidence of local adverse events (regional… read more here.
Keywords: day; day first; recombinant zoster; production ... See more keywords
In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0010
Abstract: SOURCE CITATION Goud R, Lufkin B, Duffy J, et al. Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries. JAMA Intern Med. 2021;181:1623-30. 34724025. read more here.
Keywords: recombinant zoster; zoster vaccine; barr syndrome; guillain barr ... See more keywords